Boston Scientific Betting $1.5 Billion: Market Bets and Implications
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Review year-by-year annual performance for index funds to uncover patterns that inform proactive asset allocation.
25,727 articlesA bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
When a company's top executive sells a large chunk of stock, investors take note. This article dives into Privia Heal...
A director at Arteris disclosed disposing over 20,000 shares, split between a gift and an open-market sale. Here’s ho...
As AI reshapes tech and business, where will Nvidia stock be in 2030? This guide breaks down drivers, risks, and prac...
The latest U.S. limits on Anthropic’s Fable open the door for open-source AI, lifting demand for cheaper, self-hosted...
Netflix backed away from a Warner Bros. deal, signaling a calculated shift in strategy. Here are five practical reaso...
Alphabet is branching far beyond search, funding a sweeping AI infrastructure push. This article unpacks why wall str...
Syracuse reports a 30% drop in snow-complaint calls after deploying live GPS, dashcams, and AI. Officials say transpa...
NVIDIA helped turn early bets into life-changing gains. But can it keep delivering millionaire-maker returns? This pr...
C3.ai saw a sharp drop after its latest results, renewing debate about whether the stock is a value play or a value t...
As July 22 approaches, investors wonder if AMD stock could spark a move. This guide breaks down catalysts, risks, and...
Nebius Group stock charged higher on Wednesday amid fresh AI cloud developments. This article breaks down the catalys...